Found: 60
Select item for more details and to access through your institution.
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 71, doi. 10.1111/dom.15984
- By:
- Publication type:
- Article
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 6, p. 1, doi. 10.1002/dmrr.3418
- By:
- Publication type:
- Article
Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2014, v. 30, n. 7, p. 582, doi. 10.1002/dmrr.2525
- By:
- Publication type:
- Article
The role of incretin receptor agonists in the treatment of obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4178, doi. 10.1111/dom.15796
- By:
- Publication type:
- Article
Development and Validation of a High-Throughput Screening Method for Two Polymorphisms in the Serotonin Transporter Gene.
- Published in:
- Molecular Diagnosis & Therapy, 2009, v. 13, n. 1, p. 25, doi. 10.1007/BF03256312
- By:
- Publication type:
- Article
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02180-8
- By:
- Publication type:
- Article
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01788-6
- By:
- Publication type:
- Article
Encapsulation of Langerhans' islets: Microtechnological developments for transplantation.
- Published in:
- Engineering in Life Sciences, 2011, v. 11, n. 2, p. 165, doi. 10.1002/elsc.201000146
- By:
- Publication type:
- Article
Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 489, doi. 10.1111/dom.12838
- By:
- Publication type:
- Article
Euglycaemic glucose clamp: what it can and cannot do, and how to do it.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 10, p. 962, doi. 10.1111/dom.12703
- By:
- Publication type:
- Article
Anti-diabetic treatment regulates pro-fibrotic TGF-ß serum levels in type 2 diabetics.
- Published in:
- Diabetology & Metabolic Syndrome, 2013, v. 5, n. 1, p. 1, doi. 10.1186/1758-5996-5-48
- By:
- Publication type:
- Article
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies.
- Published in:
- Diabetes & Vascular Disease Research, 2013, v. 10, n. 4, p. 302, doi. 10.1177/1479164112465442
- By:
- Publication type:
- Article
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study.
- Published in:
- Diabetes & Vascular Disease Research, 2010, v. 7, n. 2, p. 145, doi. 10.1177/1479164109358241
- By:
- Publication type:
- Article
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.
- Published in:
- Diabetes & Vascular Disease Research, 2008, v. 5, n. 4, p. 298, doi. 10.3132/dvdr.2008.043
- By:
- Publication type:
- Article
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01481-0
- By:
- Publication type:
- Article
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patients.
- Published in:
- Endocrine (1355008X), 2017, v. 56, n. 1, p. 158, doi. 10.1007/s12020-016-1179-z
- By:
- Publication type:
- Article
Elevated Peripheral Visfatin Levels in Narcoleptic Patients.
- Published in:
- PLoS ONE, 2008, v. 3, n. 8, p. 1, doi. 10.1371/journal.pone.0002980
- By:
- Publication type:
- Article
New strategies to improve clinical outcomes for diabetic kidney disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Influence of Glucose Control and Improvement of Insulin Resistance on Microvascular Blood Flow and Endothelial Function in Patients with Diabetes Mellitus Type 2.
- Published in:
- Microcirculation, 2005, v. 12, n. 7, p. 543, doi. 10.1080/10739680500253402
- By:
- Publication type:
- Article
Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes.
- Published in:
- Journal of Diabetes Science & Technology, 2024, v. 18, n. 5, p. 1044, doi. 10.1177/19322968241267774
- By:
- Publication type:
- Article
Short communication: High prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana.
- Published in:
- Tropical Medicine & International Health, 2005, v. 10, n. 12, p. 1271, doi. 10.1111/j.1365-3156.2005.01525.x
- By:
- Publication type:
- Article
Downregulation of the Proinflammatory State of Circulating of Mononuclear Cells by Short-Term Treatment with Pioglitazone in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease.
- Published in:
- PPAR Research, 2011, p. 1, doi. 10.1155/2011/647017
- By:
- Publication type:
- Article
Differentiation of Adipocyte-Derived Adult Mesenchymal Stem Cells into Insulin Expressing Cells In Vitro.
- Published in:
- Diabetes, 2007, v. 56, p. A683
- By:
- Publication type:
- Article
Short Term Treatment with Pioglitazone Improves Adiponectin and Intact Proinsulin Levels in Type 2 Diabetic Patients with Coronary Heart Disease.
- Published in:
- Diabetes, 2007, v. 56, p. A669
- By:
- Publication type:
- Article
IRIS V-Study: Pioglitazone Reduces High-Sensitivity CRP Values in Patients with Type 2 Diabetes Under Daily Routine Conditions.
- Published in:
- Diabetes, 2007, v. 56, p. A586
- By:
- Publication type:
- Article
Impact of Diabetes Mellitus and Cardiovascular Diseases on Microvascular Blood Flow.
- Published in:
- Diabetes, 2007, v. 56, p. A586
- By:
- Publication type:
- Article
Comparison of the Dosing Accuracy of Two Insulin Injection Devices.
- Published in:
- Diabetes, 2007, v. 56, p. A535
- By:
- Publication type:
- Article
Activation of Glucose Metabolism by C-Peptide in Patients with Type 1 Diabetes Mellitus and in Healthy Control Subjects.
- Published in:
- Diabetes, 2007, v. 56, p. A337
- By:
- Publication type:
- Article
Pioglitazone Down-Regulates the mRNA Expression and Secretion of Inflammatory Proteins by Monocyte/Macrophages in Patients with Type 2 Diabetes Independent from Glycemic Control.
- Published in:
- Diabetes, 2007, v. 56, p. A188
- By:
- Publication type:
- Article
Improved Plaque Stability and Reduced Inflammation during Pioglitazone Treatment in Type 2 Diabetic Patients with CHD.
- Published in:
- Diabetes, 2007, v. 56, p. A172
- By:
- Publication type:
- Article
Elastic Properties of Central Arteries in Type 1 Diabetic Patients Compared with Non-Diabetic Controls during Low and High Insulin Infusion.
- Published in:
- Diabetes, 2007, v. 56, p. A171
- By:
- Publication type:
- Article
Influence of a Treatment with Pioglitazone or Simvastatin on Retinol Binding Protein 4 in Patients with Normoglycemic Insulin Resistance.
- Published in:
- Diabetes, 2007, v. 56, p. A163
- By:
- Publication type:
- Article
A Successful Switch from Insulin to Pioglitazone/Glimepiride Improves the Cardiovascular Risk Profile in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A162
- By:
- Publication type:
- Article
The Novel, Potent, and Selective DPP-IV Inhibitor BI 1356 Significantly Lowers HbA1c after only 4 Weeks of Treatment in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A157
- By:
- Publication type:
- Article
BNP Is a Predictor for Possible Future Development of Heart Failure in Patients with Edema Development During Glitazone Therapy.
- Published in:
- Diabetes, 2007, v. 56, p. A65
- By:
- Publication type:
- Article
Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 4, p. 942, doi. 10.1111/bcp.15990
- By:
- Publication type:
- Article
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial.
- Published in:
- Diabetes Care, 2015, v. 38, n. 7, p. 1263, doi. 10.2337/dc14-1984
- By:
- Publication type:
- Article
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled With Newly Initiated and Continuously Titrated Basal Insulin Glargine.
- Published in:
- Diabetes Care, 2013, v. 36, n. 9, p. 2497, doi. 10.2337/dc12-2462
- By:
- Publication type:
- Article
Postprandial Vascular Effects of VIAject Compared With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2010, v. 33, n. 1, p. 116, doi. 10.2337/dc09-0411
- By:
- Publication type:
- Article
Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State.
- Published in:
- Diabetes Care, 2008, v. 31, n. 5, p. 1021, doi. 10.2337/dc07-2185
- By:
- Publication type:
- Article
Development and Validation of a New Measure to Evaluate Psychological Resistance to Insulin Treatment.
- Published in:
- Diabetes Care, 2007, v. 30, n. 9, p. 2199, doi. 10.2337/dc06-2042
- By:
- Publication type:
- Article
Cardiovascular Benefits of GLP-1-Based Therapies in Patients with Diabetes Mellitus Type 2: Effects on Endothelial and Vascular Dysfunction beyond Glycemic Control.
- Published in:
- Experimental Diabetes Research, 2012, p. 1, doi. 10.1155/2012/635472
- By:
- Publication type:
- Article
C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients.
- Published in:
- Experimental Diabetes Research, 2009, p. 1, doi. 10.1155/2008/730594
- By:
- Publication type:
- Article
New Tricks by an Old Dog.
- Published in:
- Experimental Diabetes Research, 2009, p. 1, doi. 10.1155/2008/384219
- By:
- Publication type:
- Article
C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients.
- Published in:
- Experimental Diabetes Research, 2008, p. 1, doi. 10.1155/2008/730594
- By:
- Publication type:
- Article